Sobi opens North American operations
September 22, 2014 11:07 ET
|
Swedish Orphan Biovitrum AB (publ)
STOCKHOLM, Sweden, Sept. 22, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) today formally opened the company's new North American office in Waltham, Massachusetts with a ribbon...
Sobi awarded Company of the Year at the European Mediscience Awards 2014
July 01, 2014 03:32 ET
|
Swedish Orphan Biovitrum AB (publ)
Stockholm, Sweden, July 1, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) has been awarded the Company of the Year Award at the European Mediscience Awards 2014. The Company of the...
Sobi Establishes North American Office in Massachusetts
June 05, 2014 02:08 ET
|
Swedish Orphan Biovitrum AB (publ)
STOCKHOLM, Sweden, June 5, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced that the Company has decided to establish its North American operations in Waltham,...
Swedish Orphan Biovitrum AB (publ): Resolutions from Sobi's AGM
May 08, 2014 12:35 ET
|
Swedish Orphan Biovitrum AB (publ)
Stockholm, Sweden, May 8, 2014 (GLOBE NEWSWIRE) -- The Swedish Orphan Biovitrum AB (publ) (Sobi) Annual General meeting (AGM) convened earlier today in Stockholm and voted in favour of the resolutions...
Swedish Orphan Biovitrum AB (publ): Annette Clancy joins Sobi's Board of Directors
May 08, 2014 12:34 ET
|
Swedish Orphan Biovitrum AB (publ)
Stockholm, Sweden, May 8, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) Annual General meeting (AGM) today elected Annette Clancy to Sobi's Board of Directors. Ms. Clancy has over...
Notice of annual general meeting in Swedish Orphan Biovitrum AB (publ)
April 03, 2014 02:09 ET
|
Swedish Orphan Biovitrum AB (publ)
STOCKHOLM, Sweden, April 3, 2014 (GLOBE NEWSWIRE) -- The shareholders in Swedish Orphan Biovitrum AB (publ), Reg. No. 556038-9321, are hereby summoned to the annual general meeting (the "Meeting"), to...
Sobi assumes direct responsibility for Orfadin(r) (nitisinone) in US and Canada and introduces Orfadin4U(TM)
April 01, 2014 02:07 ET
|
Swedish Orphan Biovitrum AB (publ)
STOCKHOLM, Sweden, April 1, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) today assumed direct responsibility for the distribution of its proprietary product Orfadin in the United...
Sobi: US FDA approves Alprolix(TM)
March 31, 2014 02:05 ET
|
Swedish Orphan Biovitrum AB (publ)
STOCKHOLM, Sweden, March 31, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB's (publ) (Sobi) partner Biogen Idec have announced that the US Food and Drug Administration (FDA) has approved...
Sobi: Kiobrina pivotal phase 3 study did not meet primary endpoint
March 26, 2014 08:08 ET
|
Swedish Orphan Biovitrum AB (publ)
STOCKHOLM, March 26, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced topline data from the company's pivotal phase 3 study of its enzyme therapy Kiobrina (rhBSSL -...
Health Canada approves Alprolix(TM)
March 21, 2014 08:08 ET
|
Swedish Orphan Biovitrum AB (publ)
Stockholm, Sweden, March 21, 2014 (GLOBE NEWSWIRE) -- Swedish Orphan Biovitrum AB's (pupl) (Sobi) partner Biogen Idec today announced that Health Canada has approved Alprolix(TM) (Coagulation Factor...